Time-dependent Cox regression models showed that the use of VEGFR-TKIs was a risk factor associated with AAD, even in patients with adjusted hypertension history; new-onset hypertension had no significant outcome (eTable 6 in Supplement 1). This evidence concerns the gene KDR and hypertensive disorder.